AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2013
Apr 4, 2013
30339_dirs_2013-04-04_765d22e0-9ad1-4f24-a5c3-049f6bd1be7e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-02-19
Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-02-19 | Stock Option (Right to Buy) | $59.1100 | A | 105356.0000 | Acquired | 2023-02-19 | Common Stock (105356.0000) | Direct |
Footnotes
F1: Due to an administrative error, the original stock option grant amount of 87,796 was incorrect. This amended Form 4 now contains the correct stock option grant amount of 105,356.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27